FOXP3 and melanoma: As observed in many aggressive solid tumors, Foxp3+CD4+Treg infiltrated into BrafV600E/Pten-driven melanoma and melanoma-associated tdLN and intratumoral Treg exhibited potent activity of suppressing T cell activation (Fig. S1).